StockTipsArenaBeta

BUY Jubilant Pharmova Limited — Vishvesh Chauhan, ChaseAlpha

BUYJubilant Pharmova Limited
Jubilant Pharmova share price target & all analyst calls

byVishvesh Chauhan, ChaseAlphaHorizon: NA (inferred Swing (≤2wk))15 Sept 2026via Zee Business (Live)

Entry₹1,040Inferred
Target₹1,200
Total upside +15.38% (call closed)
Stop loss₹970-6.73% risk
At expiry₹1,067.0528 Sept 2026, 3:30 pm
Expired+2.60%
Follow Vishvesh Chauhan for new calls(33% target hit, 15 closed calls)Get alertsWatch JUBLPHARMA for new buy/sell callsGet alertsSee 204 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 28 Sept 2026
1 supporting1 neutral2 opposing
Supports the BUY call (1)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·23 Sept · 5d ago

Neutral / worth noting (1)

Jubilant Pharmova's US CMO facility gets 'Voluntary Action Indicated' classification

NewsCnbc-Tv18·11 Sept · 2w ago

(opens in new tab)
Weighs against the BUY call (2)

Jubilant Pharmova Gets ₹87.31 Crore GST Notice From Mysore Tax Authorities For FY23

NewsGoogle News·1 Sept · 4w ago

(opens in new tab)

Jubilant Pharmova: ₹87 கோடி GST நோட்டீஸ்! அதிரடியாக மறுப்பு தெரிவித்த நிறுவனம்

NewsGoogle News·1 Sept · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Jubilant Pharmova

All analyst calls on Jubilant Pharmova

More from Vishvesh Chauhan, ChaseAlpha

Every call and its outcome